The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1219
ISSUE1219
October 10, 2005
Tipranavir (Aptivus) for HIV
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Tipranavir (Aptivus) for HIV
October 10, 2005 (Issue: 1219)
Tipranavir (Aptivus - Boehringer Ingelheim), a new protease inhibitor, has received accelerated approval from the FDA. It must be given with ritonavir (Norvir). The combination is indicated for use with other antiretrovirals to treat HIV infection in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.